Seminar 5 – Facing the Perfect Storm

empowered by the push from rapid technology development - how Nordic life science-ecosystems need to adapt responding to increased pull from payors and patients

Seminar 5 – Facing the Perfect Storm

14:00 - 15:30 Conference Room B

We are currently going through an unprecedented era of scientific, medical and technological innovation. The shift from a one-size-fits-all model to more targeted and individualized care has a suite of implications for all players across the healthcare life science ecosystem; forcing payers, providers, and drug and device manufacturers to rethink their business, operating, and collaboration models. This session will discuss how Nordic ecosystem players need to mobilize and how to take advantage of strongholds in the Nordic countries to take a globally leading position when cross-functional collaboration will be a necessity and key competences will be a scarcity.

Hosted by:

SwedenBIO

SwedenBIO

Sponsored by:

Astrazeneca

Astrazeneca

Arthur D. Little

Arthur D. Little

Moderator(s): Dr. Ulrica Sehlstedt - Partner, Arthur D. Little

Speaker(s):
Dr. Thomas Unger - Associate Director, Arthur D. Little Dr. Magnus R. Björsne - CEO, AZ BioVentureHub Dr. Annette Bak - Senior Director – Head of Advanced Drug Delivery, AstraZeneca

full program